Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

831
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
831
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

451
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
451
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

1.4K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.4K
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

131.6K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.6K
Depression: Overview01:18

Depression: Overview

800
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
800

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuronal overexpression of "readthrough" acetylcholinesterase is associated with antisense-suppressible behavioral impairments.

Molecular psychiatry·2002
Same author

Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2001
Same author

Modified testicular expression of stress-associated "readthrough" acetylcholinesterase predicts male infertility.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2001
Same author

Acetylcholinesterase--new roles for an old actor.

Nature reviews. Neuroscience·2001
Same author

Complex host cell responses to antisense suppression of ACHE gene expression.

Antisense & nucleic acid drug development·2001
Same author

Antisense prevention of neuronal damages following head injury in mice.

Journal of molecular medicine (Berlin, Germany)·2000

Related Experiment Video

Updated: Jan 19, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

528

Ejaculatory dysfunction and depression: pharmacological and psychobiological interactions.

S Seidman1

  • 1Department of Psychiatry, Columbia University College of Physicians & Surgeons, New York, NY 10032, USA. sns5@columbia.edu

International Journal of Impotence Research
|September 6, 2006
PubMed
Summary

Antidepressant-associated sexual dysfunction, particularly from SSRIs, impacts treatment adherence. This review explores its mechanisms, links to depression, and treatment options.

More Related Videos

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

796
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.2K

Related Experiment Videos

Last Updated: Jan 19, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

528
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

796
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.2K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • Widespread use of serotonin-specific reuptake inhibitors (SSRIs) has increased focus on antidepressant-associated sexual dysfunction.
  • Sexual side effects like delayed ejaculation and anorgasmia can negatively impact patient compliance.
  • Depression and aging are also recognized factors contributing to sexual dysfunction.

Purpose of the Study:

  • To review central mediators of orgasmic function and dysfunction.
  • To examine the relationship between depression and sexual dysfunction.
  • To discuss mechanisms of SSRI-associated sexual dysfunction and current treatment strategies.

Main Methods:

  • Literature review of studies on sexual dysfunction and antidepressant use.
  • Analysis of neurobiological pathways involved in orgasm.
  • Examination of clinical data linking depression, aging, and SSRI treatment to sexual side effects.

Main Results:

  • Serotonergic antidepressants are frequently associated with delayed ejaculation and anorgasmia.
  • Sexual dysfunction is multifactorial, involving central mediators, depression, and aging.
  • Understanding these factors is crucial for managing SSRI-associated sexual dysfunction.

Conclusions:

  • SSRI-associated sexual dysfunction is a significant clinical issue impacting treatment adherence.
  • Further research into central mediators and personalized treatment strategies is warranted.
  • Addressing sexual dysfunction is essential for comprehensive patient care in antidepressant therapy.